Abstract
Background
Percutaneous endoscopic gastrostomy (PEG) is used for nutritional support during treatment in patients with head and neck cancer, but long-term nutritional outcomes have not been reported in detail. The purpose of this study was to determine short- and long-term outcomes and success in meeting nutritional goals in patients with head and neck cancer who had PEGs placed over an 18-year period.
Methods
Medical records of all patients who had PEG procedures performed by one of the authors (REB) from 1997 through 2010 were reviewed. Demographic data, patient weights, timing of procedure in relation to cancer treatment, complications, and long-term outcomes were recorded.
Results
Five hundred and sixty-five patients with head and neck cancer underwent PEG. Mean age was 59.6 ± 13.6 years; 71 % were men. Mean follow-up was 33 ± 38 months. 99 % of PEGs were used for nutritional support. Average weight loss prior to PEG was 23 ± 17 lbs (range 0–133 lbs). Average weight loss between PEG and completion of treatment was 2.3 lbs; 44 % of patients gained weight or remained stable after PEG. There were no PEG-related deaths. Complications included cellulitis in 27 (4 %), pain in 14 (2.5 %); leakage in 11 (2 %), self-limited gastric bleeding in one patient. PEGs were used an average of 8.1 months. No PEG site tumor implants were observed. Among 366 patients treated with intention to cure, 45 % were alive an average of 68 months later.
Conclusions
PEG is both safe and efficacious in arresting weight loss and maintaining nutrition in patients undergoing surgery and/or chemoradiotherapy for head and neck cancer. PEG can be recommended for patients in whom dysphagia and weight loss is anticipated or in whom weight loss occurs as a result of their treatment; 20 % of patients will need the PEG for a year or more.
Similar content being viewed by others
References
Gauderer MW, Ponsky JL, Izant RJ (1980) Gastrostomy without laparotomy A percutaneous endoscopic technique. J Ped Surg 15(6):872–875
Hunter JG, Lauretano L, Shellito PC (1989) Percutaneous endoscopic gastrostomy in head and neck cancer patients. Ann Surg 210(1):42–46
Rabeneck L, Wray NP, Petersen NJ (1996) Long-term outcomes of patients receiving percutaneous endoscopic gastrostomy tubes. J Gen Intern Med 11:287–293
Grant DG, Bradley PT, Pothier DD, Bailey D, Caldera S, Baldwin DL, Birchall MA (2009) Complications following gastrostomy tube insertion in patients with head and neck cancer: a prospective multi-institution study, systematic review and metaanalysis. Clin Otolaryngol 34:103–112
Ahmed KA, Samant S, Vieira F (2005) Gastrostomy tubes in patients with advanced head and neck cancer. Laryngoscope 115(1):44–47
McLaughlin BT, Gokhale AS, Shuai Y, Diacopoulos J, Carrau R, Heron DE, Smith RP, Gibson MK, Ferris RL, Grandis JR, Johnson JT, Argiris A (2010) Management of patients treated with chemoradiotherapy for head and neck cancer without prophylactic feeding tubes: the University of Pittsburgh experience. Laryngoscope 120:71–75
Jl Locher, Bonner JA, Carroll WR, Caudell JJ, Keith JN, Kilgore ML, Ritchie CS, Roth DL, Tajeu GS, Allison JJ (2011) Prophylactic percutaneous endoscopic gastrostomy in treatment of head and neck cancer: a comprehensive review and call for evidence based medicine. J Parenter Enteral Nutr 35(3):365–374
Lawson JD, Gaultney J, Saba N, Grist W, Davis L, Johnstone PA (2009) Percutaneous feeding tubes in patents with head and neck cancer: rethinking prophylactic placement for patients undergoing chemoradiation. Am J Otolaryngol 30(4):244–249
Raykher A, Correa L, Russo L, Brown P, Lee N, Pfister D, Gerdes H, Shah J, Kraus D, Schattner M, Shike M (2009) The role of pretreatment percutaneous endoscopic gastrostomy in facilitating therapy of head and neck cancer and optimizing the body mass index of the obese patient. J Parenter Enteral Nutr 33(4):404–410
Itkin M, DeLegge H, Fang JC, McClave SA, Kundu S, d’Othee BJ, Martinez-Salazar G, Sacks D, Swan T, Tobin R, Walker G, Wojak J, Zuckerman D, Cardella J (2011) Multidisciplinary practical guidelines for gastrointestinal Access for enteral nutrition and decompression. J Vasc Interv Radiol 22:1089–1106
Smith BM, Perring P, Engoren M, Sferra JJ (2008) Hospital and long-term outcome after percutaneous endoscopic gastrostomy. Surg Endosc 22:75–80
Morgenstern L, Laquer M, Treyzon L (2005) Ethical challenges of percutaneous endoscopic gastrostomy. Surg Endosc 19:398–400
Wolf GT, Forastiere A, Ang K, Brockstein B, Conley C, Goepfert H, Kraus D, Lefevre J, Pajak TF, Pfister D, Urba S (1999) Organ preservation strategies in advanced head and neck cancer–current status and future directions. Head Neck 21:689–693
Urba SG, Forastiere AA, Wolf GT, Esclamado RM, McLaughln PW, Thornton AF (1994) Intensive induction chemotherapy and radiation for organ preservation in patients with advanced resectable head and neck carcinoma. J Clin Oncol 12(5):946–953
Adelson RT, Yadranko D (2005) Metastatic head and neck carcinoma to a percutaneous endoscopic gastrostomy site. Head Neck 27:339–343
Disclosures
Drs. Burney and Bryner have no conflicts of interest or financial ties to disclose.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Burney, R.E., Bryner, B.S. Safety and long-term outcomes of percutaneous endoscopic gastrostomy in patients with head and neck cancer. Surg Endosc 29, 3685–3689 (2015). https://doi.org/10.1007/s00464-015-4126-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00464-015-4126-9